Bg pattern

CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Cisatracurium Sala 5 mg/ml Solution for Injection and Infusion EFG

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the pack:

  1. What Cisatracurium Salais and what it is used for
  2. What you need to know before you use Cisatracurium Sala
  3. How to use Cisatracurium Sala
  4. Possible side effects
  5. Storage of Cisatracurium Sala
  6. Contents of the pack and further information

1. What is Cisatracurium Sala and what is it used for

Cisatracurium Sala contains the active substance cisatracurium, which belongs to a group of medicines called muscle relaxants.

Cisatracurium Sala is used:

  • to relax muscles during surgical operations, including cardiac surgery, in both adults and children over 1 month of age.
  • to facilitate the insertion of a tube into the trachea (tracheal intubation), if mechanical assistance to breathe is required.
  • to relax muscles in adults in Intensive Care.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Cisatracurium Sala

Do not use Cisatracurium Sala:

  • if you are allergic to cisatracurium, to any other muscle relaxant, or to any of the other ingredients of Cisatracurium Sala (listed in section 6)
  • if you have previously had an allergic reaction to an anesthetic.

Do not use Cisatracurium Sala if any of the above applies to you. If you are not sure, talk to your doctor, nurse, or pharmacist before using Cisatracurium Sala.

Warnings and precautions

Talk to your doctor, nurse, or pharmacist before using Cisatracurium Sala:

  • if you have muscle weakness, tiredness, or difficulty coordinating your movements (myasthenia gravis)
  • if you have a neuromuscular disease that causes muscle wasting, paralysis, motor neuron disease, or cerebral palsy
  • if you have had burns that required medical attention

If you are not sure if any of the above applies to you, talk to your doctor, nurse, or pharmacist before you are given Cisatracurium Sala.

Other medicines and Cisatracurium Sala

Tell your doctor if you are using, have recently used, or might use any other medicines, including those obtained without a prescription. This includes herbal products or medicines obtained without a doctor's prescription.

In particular, tell your doctor if you are taking any of the following medicines:

  • anesthetics (used to reduce sensitivity or pain during surgery)
  • antibiotics (used to treat infections)
  • medicines used to treat heart rhythm disorders (anti-arrhythmics)
  • medicines used to treat high blood pressure (hypertension)
  • medicines that help you lose fluids (diuretics), such as furosemide
  • medicines for joint inflammation, such as chloroquine or D-penicillamine
  • corticosteroids
  • medicines for seizures (epilepsy), such as phenytoin or carbamazepine
  • medicines used in psychiatry, such as lithium, or chlorpromazine (which may also be used to prevent vomiting)
  • medicines that contain magnesium (such as those used to treat indigestion or heartburn)
  • anticholinesterases used to treat Alzheimer's disease, such as donepezil.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

A harmful effect of cisatracurium on the breastfed baby cannot be excluded; however, it is not expected to occur if breastfeeding is resumed after the effects of the substance have disappeared. Cisatracurium is rapidly eliminated from the body. Women should not breastfeed for 3 hours after the end of treatment.

Driving and using machines

If you are going to be in the hospital for only one day, your doctor will tell you how long you should wait before you can drive and use machinery. It may be dangerous to drive soon after surgery.

3. How to use Cisatracurium Sala

How the injection is given

Under no circumstances should you try to give yourself this medicine. It should always be given by a qualified person.

Cisatracurium Sala can be given:

  • as a single injection into a vein (intravenous bolus injection)
  • as a continuous infusion into a vein. This is when the medicine is given slowly over a long period of time.

Your doctor will decide on the dose and duration of treatment that they consider suitable for your operation.

This will depend on:

  • your body weight
  • the amount and duration of muscle relaxation desired
  • the patient's expected response to the medicine.

The use of this medicine is not recommended in children under 1 month of age.

If you receive more Cisatracurium Sala than you should

Cisatracurium Sala will always be given under properly controlled conditions. However, if you think you have been given more medicine than you should, tell your doctor or nurse immediately.

If you have any further questions on the use of this product, ask your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet.

Allergic reactions (affect less than 1 in 10,000 people treated)

If you have had an allergic reaction, tell your doctor or nurse immediately. The signs may include:

  • sudden wheezing, chest pain, or tightness
  • swelling of the eyelids, face, lips, mouth, or tongue
  • skin rash or hives anywhere on the body
  • collapse and anaphylactic shock.

Talk to your doctor, nurse, or pharmacist if you notice any of the following:

Common side effects (affect between 1 and 10 in 100 people treated)

  • slow heart rate
  • low blood pressure (hypotension).

Uncommon side effects (affect between 1 and 10 in 1,000 people treated)

  • rash, redness of the skin
  • wheezing or coughing.

Rare side effects (affect less than 1 in 10,000 people treated)

  • muscle weakness or pain

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Cisatracurium Sala

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date is the last day of the month shown.

Do not use this medicine if you notice visible signs of deterioration in the appearance of the solution.

Cisatracurium Sala remains stable for 21 days at 25°C. Store in a refrigerator (between 2°C and 8°C). Do not freeze.

Store in the original packaging to protect from light.

If diluted, store the infusion solution between 2°C and 8°C and use within 24 hours. Any unused infusion solution should be discarded after 24 hours.

Medicines should not be disposed of via wastewater or household waste. Your doctor or nurse will dispose of any unused medicine. This will help protect the environment.

6. Contents of the pack and further information

Composition of Cisatracurium Sala

  • The active substance is cisatracurium (as besylate)
  • The other ingredients are: benzenesulfonic acid and water for injections.

Appearance of the product and pack contents

Cisatracurium 5 mg/ml Solution for Injection and Infusion EFG is presented in boxes containing one 30 ml glass vial. Each 30 ml vial contains 150 mg of cisatracurium.

Marketing authorisation holder and manufacturer:

Laboratorio Reig Jofré, S.A.

Gran Capitán, 10

08970 Sant Joan Despí, Barcelona

Spain

Date of last revision of this leaflet:June 2020

Detailed and up-to-date information on this medicine is available on the website of the Spanish Medicines and Healthcare Products Agency (AEMPS)http://www.aemps.gob.es

------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

This product is for single use only. Use only clear and almost colorless or slightly yellowish/greenish solutions. The product should be visually inspected before use, and if the appearance has changed or the container is damaged, the product should be discarded.

Cisatracurium Sala remains physically and chemically stable for at least 24 hours at 5°C and 25°C at concentrations between 0.1 and 2 mg/ml in the following infusion fluids, either in polyvinyl chloride or polypropylene containers.

Intravenous infusion of sodium chloride (0.9% w/v).

Intravenous infusion of glucose (5% w/v).

Intravenous infusion of sodium chloride (0.18% w/v) and glucose (4% w/v).

Intravenous infusion of sodium chloride (0.45% w/v) and glucose (2.5% w/v).

In any case, since the product does not contain antimicrobial preservatives, the dilution should be made immediately before use or, if this is not possible, it can be stored at 2-8°C for no more than 24 hours.

Cisatracurium Sala has been shown to be compatible with the following medicines commonly used in surgical operations, when mixed under conditions simulating intravenous infusion through a "Y" device: alfentanil hydrochloride, droperidol, fentanyl citrate, midazolam hydrochloride, and sufentanil citrate. When other medicines are administered through the same needle or cannula as Cisatracurium Sala, it is recommended that each medicine be flushed with an adequate volume of a suitable intravenous fluid, such as sodium chloride infusion (0.9% w/v).

As with other intravenous medicines, when a small vein is chosen as the injection site, Cisatracurium Sala should be flushed with a suitable infusion fluid, such as sodium chloride infusion (0.9% w/v).

Disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations.

Online doctors for CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION

Discuss questions about CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (17)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance. His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation. Patients commonly consult Dr Daniel Cichi for: 

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • sexually transmitted infections, erectile dysfunction;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders, weight loss, hair loss;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.

Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (1055)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
5.0 (41)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
The active ingredient in CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is cisatracurium. This information helps identify medicines with the same composition but different brand names.
Who manufactures CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is manufactured by Laboratorio Reig Jofre, S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CISATRACURIO SALA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION?
Other medicines with the same active substance (cisatracurium) include CISATRACURIO ACCORDPHARMA 2 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION, CISATRACURIO ACCORDPHARMA 5 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION, CISATRACURIO HIKMA 2 mg/ml INJECTABLE SOLUTION AND PERFUSION SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media